Key Insights
The Asia-Pacific (APAC) diabetes care devices market, valued at approximately $X million in 2025, is projected to experience robust growth, driven by several key factors. The rising prevalence of diabetes across the region, particularly in countries like China, India, and Japan, is a primary driver. Aging populations and increasing urbanization contribute to this rise, alongside lifestyle changes like sedentary habits and unhealthy diets. Technological advancements in diabetes management, such as the development of more accurate and user-friendly continuous glucose monitoring (CGM) systems and sophisticated insulin pumps (both tethered and tubeless), are further fueling market expansion. Increased healthcare expenditure and rising awareness of diabetes management among the population are also significant contributors to market growth. However, high costs associated with advanced devices, limited access to healthcare in certain areas, and the need for consistent patient education and adherence pose challenges to the market's full potential. The market segmentation reveals a strong demand for insulin pumps, CGM devices, and insulin pens, particularly in developed economies within APAC, like Japan and South Korea, while the demand for simpler self-monitoring blood glucose (SMBG) devices remains high in developing economies. This difference in segment performance highlights the diverse needs and varying levels of healthcare infrastructure across the APAC region. The market's growth is anticipated to remain steady throughout the forecast period, with a projected CAGR of 3.5% between 2025 and 2033, indicating a considerable expansion potential. Competitive pressures among major players and ongoing innovation in technology will continue shaping the market landscape.
APAC Diabetes Care Devices Industry Market Size (In Billion)
Given the global CAGR of 3.5% and the significant diabetic population in APAC, it's reasonable to assume that the APAC region will mirror or slightly exceed this growth rate. Considering the 2025 global market size of $22.77 billion, and estimating a 40% market share for APAC (due to its large and rapidly growing diabetic population), the 2025 APAC market size can be estimated at approximately $9.1 billion. Using the projected CAGR, a yearly growth trajectory can be calculated for the forecast period. Factors such as increased disposable incomes in some APAC nations, improving healthcare infrastructure, and government initiatives to tackle diabetes will likely contribute to slightly above-average growth in the region. However, affordability and accessibility constraints in less-developed areas remain key challenges. The competitive landscape within APAC is intense, with both international and domestic companies vying for market share, leading to innovation and pricing pressures.
APAC Diabetes Care Devices Industry Company Market Share
APAC Diabetes Care Devices Industry Report: 2019-2033
This comprehensive report provides an in-depth analysis of the Asia-Pacific diabetes care devices market, offering valuable insights for stakeholders seeking to navigate this rapidly evolving landscape. The report covers the period 2019-2033, with a focus on the 2025-2033 forecast period. The market is valued at xx Million in 2025 and is projected to reach xx Million by 2033, exhibiting a significant Compound Annual Growth Rate (CAGR). Key players like Terumo, Dexcom, Medtronic, and Abbott Diabetes Care are shaping the market's trajectory, alongside emerging innovators. This report will equip you with the strategic intelligence needed to make informed decisions in this dynamic sector.
APAC Diabetes Care Devices Industry Market Composition & Trends
The APAC diabetes care devices market is characterized by a moderately concentrated landscape, with several multinational corporations holding significant market share. However, the emergence of innovative Chinese companies and increasing domestic production are leading to a more competitive environment. Market share distribution in 2025 is estimated as follows: Medtronic (xx%), Abbott Diabetes Care (xx%), Dexcom (xx%), and others (xx%). The market is driven by factors such as the rising prevalence of diabetes, increasing awareness of advanced treatment options, and supportive government initiatives. Regulatory landscapes vary across countries, influencing market access and pricing strategies. Substitute products, such as lifestyle modifications and alternative therapies, present a competitive challenge. The end-user segment is largely split between hospital/clinics and home/personal use, with the latter demonstrating faster growth. M&A activity has been moderate, with deal values averaging around xx Million in recent years. Key M&A trends include the acquisition of smaller companies with innovative technologies by larger players.
- Market Concentration: Moderately concentrated, with several key players dominating.
- Innovation Catalysts: Rising prevalence of diabetes, technological advancements, government support.
- Regulatory Landscape: Varies across countries, impacting market access.
- Substitute Products: Lifestyle modifications and alternative therapies pose competition.
- End-User Profile: Hospital/clinics and home/personal use, with the latter showing faster growth.
- M&A Activity: Moderate, with deal values averaging xx Million.
APAC Diabetes Care Devices Industry Industry Evolution
The APAC diabetes care devices market has witnessed substantial growth over the historical period (2019-2024), driven primarily by the increasing prevalence of diabetes across the region. This growth is projected to continue throughout the forecast period (2025-2033), with a CAGR of xx%. Technological advancements, such as the development of continuous glucose monitoring (CGM) systems and tubeless insulin pumps, have significantly enhanced the treatment of diabetes, driving market expansion. Consumer demand is shifting towards more convenient, user-friendly, and accurate devices, leading to innovation in areas like mobile app integration and improved data management capabilities. The adoption of CGMs has shown significant growth, with an estimated xx% penetration in 2025, projected to increase to xx% by 2033. Furthermore, the market is witnessing a shift towards the adoption of insulin pumps, although initial high cost remains a barrier for many. This is expected to change as the technologies become more affordable. The growing integration of artificial intelligence (AI) and machine learning into diabetes management technologies also represents a significant growth opportunity.
Leading Regions, Countries, or Segments in APAP Diabetes Care Devices Industry
Dominant Region: India and China are currently the leading markets due to their large diabetic populations and increasing healthcare spending. Japan and South Korea also contribute significantly to the overall market size.
Dominant Segments:
- Lancets: The market for lancets is experiencing steady growth, driven by the continued reliance on self-monitoring blood glucose (SMBG) testing.
- Continuous Glucose Monitoring (CGM): CGM is the fastest-growing segment, fueled by technological advancements and improved accuracy.
- End User: The home/personal use segment is outpacing the hospital/clinics segment due to increasing affordability and patient preference for self-management.
- Management Devices: Insulin pumps are experiencing moderate growth, driven by technological advancements and improved patient outcomes.
- Technology: Tubeless insulin pumps are gaining traction due to improved convenience and reduced infection risk.
- Components: Insulin pump devices, reservoirs, and infusion sets are key components driving market growth.
- Insulin Pens: Insulin pens continue to be widely used, with disposable pens gaining popularity.
- Insulin Disposable Pens: Insulin syringes and jet injectors maintain a significant share due to their cost-effectiveness.
- Monitoring Devices: Self-monitoring blood glucose (SMBG) devices remain a significant segment, despite the increasing adoption of CGMs.
Key Drivers:
- Increasing Prevalence of Diabetes: The rising incidence of diabetes across the APAC region is the primary driver of market growth.
- Government Initiatives and Healthcare Reforms: Increased healthcare spending and government initiatives supporting diabetes management are propelling market growth.
- Technological Advancements: Innovations in CGM, insulin pumps, and data management technologies are driving market expansion.
- Rising Healthcare Expenditure: Increased disposable incomes and healthcare insurance coverage are contributing to higher healthcare spending.
APAC Diabetes Care Devices Industry Product Innovations
Recent product innovations focus on enhancing the accuracy, convenience, and usability of diabetes management devices. Continuous glucose monitoring (CGM) systems with longer wear times and improved data analytics capabilities are gaining popularity. Tubeless insulin pumps offer increased convenience and reduced infection risk, while smart insulin pens integrate with mobile apps for improved data management and medication adherence. The incorporation of artificial intelligence (AI) in data analysis promises more personalized treatment plans and improved patient outcomes. These innovations are increasingly focused on reducing the burden of diabetes management for patients, thereby improving their quality of life.
Propelling Factors for APAC Diabetes Care Devices Industry Growth
The APAC diabetes care devices market is propelled by several key factors: the escalating prevalence of diabetes, fueled by lifestyle changes and aging populations; growing government initiatives and healthcare investments; technological advancements, including the development of more accurate, user-friendly, and connected devices; and rising healthcare expenditure and insurance coverage, making advanced therapies more accessible. The increased awareness about diabetes management through public health campaigns further contributes to market growth.
Obstacles in the APAC Diabetes Care Devices Industry Market
Significant barriers to market growth include the high cost of advanced devices like insulin pumps and CGMs, limiting their accessibility, particularly in lower-income populations. Regulatory hurdles vary across countries, impacting market entry and pricing strategies. Supply chain disruptions and fluctuations in raw material prices present operational challenges. Furthermore, intense competition among established players and emerging innovators puts pressure on pricing and profit margins. These factors collectively pose challenges to consistent, sustainable market expansion.
Future Opportunities in APAC Diabetes Care Devices Industry
Future opportunities lie in expanding market access through affordable solutions and government partnerships. The development and adoption of innovative technologies such as closed-loop systems and artificial pancreas systems offer significant potential. Addressing unmet needs in specific patient populations, such as elderly individuals or those with limited digital literacy, will drive innovation and expansion. Further, tapping into the growing telehealth and remote monitoring market provides substantial opportunities.
Major Players in the APAC Diabetes Care Devices Industry Ecosystem
Key Developments in APAC Diabetes Care Devices Industry Industry
November 2023: Sibionics receives CE Mark for its GS1 CGM system, a 14-day wearable device with seamless data transmission to mobile devices. This significantly enhances the convenience and data accessibility for patients using CGM technology.
August 2022: Ypsomed launches smartphone bolus delivery for its mylife YpsoPump, improving user convenience and discretion in insulin delivery. This advancement aligns with the growing demand for user-friendly and digitally integrated diabetes management solutions.
Strategic APAC Diabetes Care Devices Industry Market Forecast
The APAC diabetes care devices market is poised for sustained growth, driven by the continued increase in diabetes prevalence, technological advancements, and favorable regulatory environments. The growing adoption of advanced technologies like CGMs and insulin pumps, along with increasing integration with mobile health applications, presents significant opportunities for market expansion. The market's future growth will be shaped by factors such as affordability, healthcare access, and the ongoing development of innovative and user-friendly diabetes management solutions. The continued focus on personalized medicine and remote patient monitoring will further propel market expansion in the coming years.
APAC Diabetes Care Devices Industry Segmentation
-
1. Management Devices
-
1.1. Insulin Pump
-
1.1.1. Technology
- 1.1.1.1. Tethered Insulin Pump
- 1.1.1.2. Tubeless Insulin Pump
-
1.1.2. Component
- 1.1.2.1. Insulin Pump Device
- 1.1.2.2. Insulin Pump Reservoir
- 1.1.2.3. Infusion Set
-
1.1.1. Technology
-
1.2. Insulin pens
- 1.2.1. Cartridges in Reusable Pens
- 1.2.2. Insulin Disposable Pens
- 1.3. Insulin Syringes
- 1.4. Jet Injectors
-
1.1. Insulin Pump
-
2. Monitoring Devices
-
2.1. Self-monitoring Blood Glucose
- 2.1.1. Glucometer Devices
- 2.1.2. Blood Glucose Test Strips
- 2.1.3. Lancets
-
2.2. Continuous Glucose Monitoring
- 2.2.1. Sensors
- 2.2.2. Durables (Receivers and Transmitters)
-
2.1. Self-monitoring Blood Glucose
-
3. End User
- 3.1. Hospital/Clinics
- 3.2. Home/Personal
APAC Diabetes Care Devices Industry Segmentation By Geography
-
1. North America
- 1.1. United States
- 1.2. Canada
- 1.3. Mexico
-
2. South America
- 2.1. Brazil
- 2.2. Argentina
- 2.3. Rest of South America
-
3. Europe
- 3.1. United Kingdom
- 3.2. Germany
- 3.3. France
- 3.4. Italy
- 3.5. Spain
- 3.6. Russia
- 3.7. Benelux
- 3.8. Nordics
- 3.9. Rest of Europe
-
4. Middle East & Africa
- 4.1. Turkey
- 4.2. Israel
- 4.3. GCC
- 4.4. North Africa
- 4.5. South Africa
- 4.6. Rest of Middle East & Africa
-
5. Asia Pacific
- 5.1. China
- 5.2. India
- 5.3. Japan
- 5.4. South Korea
- 5.5. ASEAN
- 5.6. Oceania
- 5.7. Rest of Asia Pacific
APAC Diabetes Care Devices Industry Regional Market Share
Geographic Coverage of APAC Diabetes Care Devices Industry
APAC Diabetes Care Devices Industry REPORT HIGHLIGHTS
| Aspects | Details |
|---|---|
| Study Period | 2020-2034 |
| Base Year | 2025 |
| Estimated Year | 2026 |
| Forecast Period | 2026-2034 |
| Historical Period | 2020-2025 |
| Growth Rate | CAGR of 3.50% from 2020-2034 |
| Segmentation |
|
Table of Contents
- 1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
- 2. Executive Summary
- 2.1. Introduction
- 3. Market Dynamics
- 3.1. Introduction
- 3.2. Market Drivers
- 3.2.1. Rising Prevalence of Cancer Worldwide; Technological Advancements in Diagnostic Testing; Increasing Demand for Point-of-care Treatment
- 3.3. Market Restrains
- 3.3.1. High Cost of Molecular Diagnostic Tests; Lack of Skilled Workforce and Stringent Regulatory Framework
- 3.4. Market Trends
- 3.4.1. The continuous glucose monitoring segment is expected to witness a healthy growth rate over the forecast period
- 4. Market Factor Analysis
- 4.1. Porters Five Forces
- 4.2. Supply/Value Chain
- 4.3. PESTEL analysis
- 4.4. Market Entropy
- 4.5. Patent/Trademark Analysis
- 5. Global APAC Diabetes Care Devices Industry Analysis, Insights and Forecast, 2020-2032
- 5.1. Market Analysis, Insights and Forecast - by Management Devices
- 5.1.1. Insulin Pump
- 5.1.1.1. Technology
- 5.1.1.1.1. Tethered Insulin Pump
- 5.1.1.1.2. Tubeless Insulin Pump
- 5.1.1.2. Component
- 5.1.1.2.1. Insulin Pump Device
- 5.1.1.2.2. Insulin Pump Reservoir
- 5.1.1.2.3. Infusion Set
- 5.1.1.1. Technology
- 5.1.2. Insulin pens
- 5.1.2.1. Cartridges in Reusable Pens
- 5.1.2.2. Insulin Disposable Pens
- 5.1.3. Insulin Syringes
- 5.1.4. Jet Injectors
- 5.1.1. Insulin Pump
- 5.2. Market Analysis, Insights and Forecast - by Monitoring Devices
- 5.2.1. Self-monitoring Blood Glucose
- 5.2.1.1. Glucometer Devices
- 5.2.1.2. Blood Glucose Test Strips
- 5.2.1.3. Lancets
- 5.2.2. Continuous Glucose Monitoring
- 5.2.2.1. Sensors
- 5.2.2.2. Durables (Receivers and Transmitters)
- 5.2.1. Self-monitoring Blood Glucose
- 5.3. Market Analysis, Insights and Forecast - by End User
- 5.3.1. Hospital/Clinics
- 5.3.2. Home/Personal
- 5.4. Market Analysis, Insights and Forecast - by Region
- 5.4.1. North America
- 5.4.2. South America
- 5.4.3. Europe
- 5.4.4. Middle East & Africa
- 5.4.5. Asia Pacific
- 5.1. Market Analysis, Insights and Forecast - by Management Devices
- 6. North America APAC Diabetes Care Devices Industry Analysis, Insights and Forecast, 2020-2032
- 6.1. Market Analysis, Insights and Forecast - by Management Devices
- 6.1.1. Insulin Pump
- 6.1.1.1. Technology
- 6.1.1.1.1. Tethered Insulin Pump
- 6.1.1.1.2. Tubeless Insulin Pump
- 6.1.1.2. Component
- 6.1.1.2.1. Insulin Pump Device
- 6.1.1.2.2. Insulin Pump Reservoir
- 6.1.1.2.3. Infusion Set
- 6.1.1.1. Technology
- 6.1.2. Insulin pens
- 6.1.2.1. Cartridges in Reusable Pens
- 6.1.2.2. Insulin Disposable Pens
- 6.1.3. Insulin Syringes
- 6.1.4. Jet Injectors
- 6.1.1. Insulin Pump
- 6.2. Market Analysis, Insights and Forecast - by Monitoring Devices
- 6.2.1. Self-monitoring Blood Glucose
- 6.2.1.1. Glucometer Devices
- 6.2.1.2. Blood Glucose Test Strips
- 6.2.1.3. Lancets
- 6.2.2. Continuous Glucose Monitoring
- 6.2.2.1. Sensors
- 6.2.2.2. Durables (Receivers and Transmitters)
- 6.2.1. Self-monitoring Blood Glucose
- 6.3. Market Analysis, Insights and Forecast - by End User
- 6.3.1. Hospital/Clinics
- 6.3.2. Home/Personal
- 6.1. Market Analysis, Insights and Forecast - by Management Devices
- 7. South America APAC Diabetes Care Devices Industry Analysis, Insights and Forecast, 2020-2032
- 7.1. Market Analysis, Insights and Forecast - by Management Devices
- 7.1.1. Insulin Pump
- 7.1.1.1. Technology
- 7.1.1.1.1. Tethered Insulin Pump
- 7.1.1.1.2. Tubeless Insulin Pump
- 7.1.1.2. Component
- 7.1.1.2.1. Insulin Pump Device
- 7.1.1.2.2. Insulin Pump Reservoir
- 7.1.1.2.3. Infusion Set
- 7.1.1.1. Technology
- 7.1.2. Insulin pens
- 7.1.2.1. Cartridges in Reusable Pens
- 7.1.2.2. Insulin Disposable Pens
- 7.1.3. Insulin Syringes
- 7.1.4. Jet Injectors
- 7.1.1. Insulin Pump
- 7.2. Market Analysis, Insights and Forecast - by Monitoring Devices
- 7.2.1. Self-monitoring Blood Glucose
- 7.2.1.1. Glucometer Devices
- 7.2.1.2. Blood Glucose Test Strips
- 7.2.1.3. Lancets
- 7.2.2. Continuous Glucose Monitoring
- 7.2.2.1. Sensors
- 7.2.2.2. Durables (Receivers and Transmitters)
- 7.2.1. Self-monitoring Blood Glucose
- 7.3. Market Analysis, Insights and Forecast - by End User
- 7.3.1. Hospital/Clinics
- 7.3.2. Home/Personal
- 7.1. Market Analysis, Insights and Forecast - by Management Devices
- 8. Europe APAC Diabetes Care Devices Industry Analysis, Insights and Forecast, 2020-2032
- 8.1. Market Analysis, Insights and Forecast - by Management Devices
- 8.1.1. Insulin Pump
- 8.1.1.1. Technology
- 8.1.1.1.1. Tethered Insulin Pump
- 8.1.1.1.2. Tubeless Insulin Pump
- 8.1.1.2. Component
- 8.1.1.2.1. Insulin Pump Device
- 8.1.1.2.2. Insulin Pump Reservoir
- 8.1.1.2.3. Infusion Set
- 8.1.1.1. Technology
- 8.1.2. Insulin pens
- 8.1.2.1. Cartridges in Reusable Pens
- 8.1.2.2. Insulin Disposable Pens
- 8.1.3. Insulin Syringes
- 8.1.4. Jet Injectors
- 8.1.1. Insulin Pump
- 8.2. Market Analysis, Insights and Forecast - by Monitoring Devices
- 8.2.1. Self-monitoring Blood Glucose
- 8.2.1.1. Glucometer Devices
- 8.2.1.2. Blood Glucose Test Strips
- 8.2.1.3. Lancets
- 8.2.2. Continuous Glucose Monitoring
- 8.2.2.1. Sensors
- 8.2.2.2. Durables (Receivers and Transmitters)
- 8.2.1. Self-monitoring Blood Glucose
- 8.3. Market Analysis, Insights and Forecast - by End User
- 8.3.1. Hospital/Clinics
- 8.3.2. Home/Personal
- 8.1. Market Analysis, Insights and Forecast - by Management Devices
- 9. Middle East & Africa APAC Diabetes Care Devices Industry Analysis, Insights and Forecast, 2020-2032
- 9.1. Market Analysis, Insights and Forecast - by Management Devices
- 9.1.1. Insulin Pump
- 9.1.1.1. Technology
- 9.1.1.1.1. Tethered Insulin Pump
- 9.1.1.1.2. Tubeless Insulin Pump
- 9.1.1.2. Component
- 9.1.1.2.1. Insulin Pump Device
- 9.1.1.2.2. Insulin Pump Reservoir
- 9.1.1.2.3. Infusion Set
- 9.1.1.1. Technology
- 9.1.2. Insulin pens
- 9.1.2.1. Cartridges in Reusable Pens
- 9.1.2.2. Insulin Disposable Pens
- 9.1.3. Insulin Syringes
- 9.1.4. Jet Injectors
- 9.1.1. Insulin Pump
- 9.2. Market Analysis, Insights and Forecast - by Monitoring Devices
- 9.2.1. Self-monitoring Blood Glucose
- 9.2.1.1. Glucometer Devices
- 9.2.1.2. Blood Glucose Test Strips
- 9.2.1.3. Lancets
- 9.2.2. Continuous Glucose Monitoring
- 9.2.2.1. Sensors
- 9.2.2.2. Durables (Receivers and Transmitters)
- 9.2.1. Self-monitoring Blood Glucose
- 9.3. Market Analysis, Insights and Forecast - by End User
- 9.3.1. Hospital/Clinics
- 9.3.2. Home/Personal
- 9.1. Market Analysis, Insights and Forecast - by Management Devices
- 10. Asia Pacific APAC Diabetes Care Devices Industry Analysis, Insights and Forecast, 2020-2032
- 10.1. Market Analysis, Insights and Forecast - by Management Devices
- 10.1.1. Insulin Pump
- 10.1.1.1. Technology
- 10.1.1.1.1. Tethered Insulin Pump
- 10.1.1.1.2. Tubeless Insulin Pump
- 10.1.1.2. Component
- 10.1.1.2.1. Insulin Pump Device
- 10.1.1.2.2. Insulin Pump Reservoir
- 10.1.1.2.3. Infusion Set
- 10.1.1.1. Technology
- 10.1.2. Insulin pens
- 10.1.2.1. Cartridges in Reusable Pens
- 10.1.2.2. Insulin Disposable Pens
- 10.1.3. Insulin Syringes
- 10.1.4. Jet Injectors
- 10.1.1. Insulin Pump
- 10.2. Market Analysis, Insights and Forecast - by Monitoring Devices
- 10.2.1. Self-monitoring Blood Glucose
- 10.2.1.1. Glucometer Devices
- 10.2.1.2. Blood Glucose Test Strips
- 10.2.1.3. Lancets
- 10.2.2. Continuous Glucose Monitoring
- 10.2.2.1. Sensors
- 10.2.2.2. Durables (Receivers and Transmitters)
- 10.2.1. Self-monitoring Blood Glucose
- 10.3. Market Analysis, Insights and Forecast - by End User
- 10.3.1. Hospital/Clinics
- 10.3.2. Home/Personal
- 10.1. Market Analysis, Insights and Forecast - by Management Devices
- 11. Competitive Analysis
- 11.1. Global Market Share Analysis 2025
- 11.2. Company Profiles
- 11.2.1 Terumo
- 11.2.1.1. Overview
- 11.2.1.2. Products
- 11.2.1.3. SWOT Analysis
- 11.2.1.4. Recent Developments
- 11.2.1.5. Financials (Based on Availability)
- 11.2.2 Dexcom
- 11.2.2.1. Overview
- 11.2.2.2. Products
- 11.2.2.3. SWOT Analysis
- 11.2.2.4. Recent Developments
- 11.2.2.5. Financials (Based on Availability)
- 11.2.3 Insulin Devices
- 11.2.3.1. Overview
- 11.2.3.2. Products
- 11.2.3.3. SWOT Analysis
- 11.2.3.4. Recent Developments
- 11.2.3.5. Financials (Based on Availability)
- 11.2.4 Roche Diabetes Care
- 11.2.4.1. Overview
- 11.2.4.2. Products
- 11.2.4.3. SWOT Analysis
- 11.2.4.4. Recent Developments
- 11.2.4.5. Financials (Based on Availability)
- 11.2.5 Eli Lilly
- 11.2.5.1. Overview
- 11.2.5.2. Products
- 11.2.5.3. SWOT Analysis
- 11.2.5.4. Recent Developments
- 11.2.5.5. Financials (Based on Availability)
- 11.2.6 Sanofi
- 11.2.6.1. Overview
- 11.2.6.2. Products
- 11.2.6.3. SWOT Analysis
- 11.2.6.4. Recent Developments
- 11.2.6.5. Financials (Based on Availability)
- 11.2.7 Abbott Diabetes Care
- 11.2.7.1. Overview
- 11.2.7.2. Products
- 11.2.7.3. SWOT Analysis
- 11.2.7.4. Recent Developments
- 11.2.7.5. Financials (Based on Availability)
- 11.2.8 Medtronic
- 11.2.8.1. Overview
- 11.2.8.2. Products
- 11.2.8.3. SWOT Analysis
- 11.2.8.4. Recent Developments
- 11.2.8.5. Financials (Based on Availability)
- 11.2.9 LifeScan (Johnson & Johnson)
- 11.2.9.1. Overview
- 11.2.9.2. Products
- 11.2.9.3. SWOT Analysis
- 11.2.9.4. Recent Developments
- 11.2.9.5. Financials (Based on Availability)
- 11.2.10 Becton Dickinson
- 11.2.10.1. Overview
- 11.2.10.2. Products
- 11.2.10.3. SWOT Analysis
- 11.2.10.4. Recent Developments
- 11.2.10.5. Financials (Based on Availability)
- 11.2.11 Novo Nordisk A/S
- 11.2.11.1. Overview
- 11.2.11.2. Products
- 11.2.11.3. SWOT Analysis
- 11.2.11.4. Recent Developments
- 11.2.11.5. Financials (Based on Availability)
- 11.2.12 Arkray
- 11.2.12.1. Overview
- 11.2.12.2. Products
- 11.2.12.3. SWOT Analysis
- 11.2.12.4. Recent Developments
- 11.2.12.5. Financials (Based on Availability)
- 11.2.1 Terumo
List of Figures
- Figure 1: Global APAC Diabetes Care Devices Industry Revenue Breakdown (Million, %) by Region 2025 & 2033
- Figure 2: Global APAC Diabetes Care Devices Industry Volume Breakdown (K Unit, %) by Region 2025 & 2033
- Figure 3: North America APAC Diabetes Care Devices Industry Revenue (Million), by Management Devices 2025 & 2033
- Figure 4: North America APAC Diabetes Care Devices Industry Volume (K Unit), by Management Devices 2025 & 2033
- Figure 5: North America APAC Diabetes Care Devices Industry Revenue Share (%), by Management Devices 2025 & 2033
- Figure 6: North America APAC Diabetes Care Devices Industry Volume Share (%), by Management Devices 2025 & 2033
- Figure 7: North America APAC Diabetes Care Devices Industry Revenue (Million), by Monitoring Devices 2025 & 2033
- Figure 8: North America APAC Diabetes Care Devices Industry Volume (K Unit), by Monitoring Devices 2025 & 2033
- Figure 9: North America APAC Diabetes Care Devices Industry Revenue Share (%), by Monitoring Devices 2025 & 2033
- Figure 10: North America APAC Diabetes Care Devices Industry Volume Share (%), by Monitoring Devices 2025 & 2033
- Figure 11: North America APAC Diabetes Care Devices Industry Revenue (Million), by End User 2025 & 2033
- Figure 12: North America APAC Diabetes Care Devices Industry Volume (K Unit), by End User 2025 & 2033
- Figure 13: North America APAC Diabetes Care Devices Industry Revenue Share (%), by End User 2025 & 2033
- Figure 14: North America APAC Diabetes Care Devices Industry Volume Share (%), by End User 2025 & 2033
- Figure 15: North America APAC Diabetes Care Devices Industry Revenue (Million), by Country 2025 & 2033
- Figure 16: North America APAC Diabetes Care Devices Industry Volume (K Unit), by Country 2025 & 2033
- Figure 17: North America APAC Diabetes Care Devices Industry Revenue Share (%), by Country 2025 & 2033
- Figure 18: North America APAC Diabetes Care Devices Industry Volume Share (%), by Country 2025 & 2033
- Figure 19: South America APAC Diabetes Care Devices Industry Revenue (Million), by Management Devices 2025 & 2033
- Figure 20: South America APAC Diabetes Care Devices Industry Volume (K Unit), by Management Devices 2025 & 2033
- Figure 21: South America APAC Diabetes Care Devices Industry Revenue Share (%), by Management Devices 2025 & 2033
- Figure 22: South America APAC Diabetes Care Devices Industry Volume Share (%), by Management Devices 2025 & 2033
- Figure 23: South America APAC Diabetes Care Devices Industry Revenue (Million), by Monitoring Devices 2025 & 2033
- Figure 24: South America APAC Diabetes Care Devices Industry Volume (K Unit), by Monitoring Devices 2025 & 2033
- Figure 25: South America APAC Diabetes Care Devices Industry Revenue Share (%), by Monitoring Devices 2025 & 2033
- Figure 26: South America APAC Diabetes Care Devices Industry Volume Share (%), by Monitoring Devices 2025 & 2033
- Figure 27: South America APAC Diabetes Care Devices Industry Revenue (Million), by End User 2025 & 2033
- Figure 28: South America APAC Diabetes Care Devices Industry Volume (K Unit), by End User 2025 & 2033
- Figure 29: South America APAC Diabetes Care Devices Industry Revenue Share (%), by End User 2025 & 2033
- Figure 30: South America APAC Diabetes Care Devices Industry Volume Share (%), by End User 2025 & 2033
- Figure 31: South America APAC Diabetes Care Devices Industry Revenue (Million), by Country 2025 & 2033
- Figure 32: South America APAC Diabetes Care Devices Industry Volume (K Unit), by Country 2025 & 2033
- Figure 33: South America APAC Diabetes Care Devices Industry Revenue Share (%), by Country 2025 & 2033
- Figure 34: South America APAC Diabetes Care Devices Industry Volume Share (%), by Country 2025 & 2033
- Figure 35: Europe APAC Diabetes Care Devices Industry Revenue (Million), by Management Devices 2025 & 2033
- Figure 36: Europe APAC Diabetes Care Devices Industry Volume (K Unit), by Management Devices 2025 & 2033
- Figure 37: Europe APAC Diabetes Care Devices Industry Revenue Share (%), by Management Devices 2025 & 2033
- Figure 38: Europe APAC Diabetes Care Devices Industry Volume Share (%), by Management Devices 2025 & 2033
- Figure 39: Europe APAC Diabetes Care Devices Industry Revenue (Million), by Monitoring Devices 2025 & 2033
- Figure 40: Europe APAC Diabetes Care Devices Industry Volume (K Unit), by Monitoring Devices 2025 & 2033
- Figure 41: Europe APAC Diabetes Care Devices Industry Revenue Share (%), by Monitoring Devices 2025 & 2033
- Figure 42: Europe APAC Diabetes Care Devices Industry Volume Share (%), by Monitoring Devices 2025 & 2033
- Figure 43: Europe APAC Diabetes Care Devices Industry Revenue (Million), by End User 2025 & 2033
- Figure 44: Europe APAC Diabetes Care Devices Industry Volume (K Unit), by End User 2025 & 2033
- Figure 45: Europe APAC Diabetes Care Devices Industry Revenue Share (%), by End User 2025 & 2033
- Figure 46: Europe APAC Diabetes Care Devices Industry Volume Share (%), by End User 2025 & 2033
- Figure 47: Europe APAC Diabetes Care Devices Industry Revenue (Million), by Country 2025 & 2033
- Figure 48: Europe APAC Diabetes Care Devices Industry Volume (K Unit), by Country 2025 & 2033
- Figure 49: Europe APAC Diabetes Care Devices Industry Revenue Share (%), by Country 2025 & 2033
- Figure 50: Europe APAC Diabetes Care Devices Industry Volume Share (%), by Country 2025 & 2033
- Figure 51: Middle East & Africa APAC Diabetes Care Devices Industry Revenue (Million), by Management Devices 2025 & 2033
- Figure 52: Middle East & Africa APAC Diabetes Care Devices Industry Volume (K Unit), by Management Devices 2025 & 2033
- Figure 53: Middle East & Africa APAC Diabetes Care Devices Industry Revenue Share (%), by Management Devices 2025 & 2033
- Figure 54: Middle East & Africa APAC Diabetes Care Devices Industry Volume Share (%), by Management Devices 2025 & 2033
- Figure 55: Middle East & Africa APAC Diabetes Care Devices Industry Revenue (Million), by Monitoring Devices 2025 & 2033
- Figure 56: Middle East & Africa APAC Diabetes Care Devices Industry Volume (K Unit), by Monitoring Devices 2025 & 2033
- Figure 57: Middle East & Africa APAC Diabetes Care Devices Industry Revenue Share (%), by Monitoring Devices 2025 & 2033
- Figure 58: Middle East & Africa APAC Diabetes Care Devices Industry Volume Share (%), by Monitoring Devices 2025 & 2033
- Figure 59: Middle East & Africa APAC Diabetes Care Devices Industry Revenue (Million), by End User 2025 & 2033
- Figure 60: Middle East & Africa APAC Diabetes Care Devices Industry Volume (K Unit), by End User 2025 & 2033
- Figure 61: Middle East & Africa APAC Diabetes Care Devices Industry Revenue Share (%), by End User 2025 & 2033
- Figure 62: Middle East & Africa APAC Diabetes Care Devices Industry Volume Share (%), by End User 2025 & 2033
- Figure 63: Middle East & Africa APAC Diabetes Care Devices Industry Revenue (Million), by Country 2025 & 2033
- Figure 64: Middle East & Africa APAC Diabetes Care Devices Industry Volume (K Unit), by Country 2025 & 2033
- Figure 65: Middle East & Africa APAC Diabetes Care Devices Industry Revenue Share (%), by Country 2025 & 2033
- Figure 66: Middle East & Africa APAC Diabetes Care Devices Industry Volume Share (%), by Country 2025 & 2033
- Figure 67: Asia Pacific APAC Diabetes Care Devices Industry Revenue (Million), by Management Devices 2025 & 2033
- Figure 68: Asia Pacific APAC Diabetes Care Devices Industry Volume (K Unit), by Management Devices 2025 & 2033
- Figure 69: Asia Pacific APAC Diabetes Care Devices Industry Revenue Share (%), by Management Devices 2025 & 2033
- Figure 70: Asia Pacific APAC Diabetes Care Devices Industry Volume Share (%), by Management Devices 2025 & 2033
- Figure 71: Asia Pacific APAC Diabetes Care Devices Industry Revenue (Million), by Monitoring Devices 2025 & 2033
- Figure 72: Asia Pacific APAC Diabetes Care Devices Industry Volume (K Unit), by Monitoring Devices 2025 & 2033
- Figure 73: Asia Pacific APAC Diabetes Care Devices Industry Revenue Share (%), by Monitoring Devices 2025 & 2033
- Figure 74: Asia Pacific APAC Diabetes Care Devices Industry Volume Share (%), by Monitoring Devices 2025 & 2033
- Figure 75: Asia Pacific APAC Diabetes Care Devices Industry Revenue (Million), by End User 2025 & 2033
- Figure 76: Asia Pacific APAC Diabetes Care Devices Industry Volume (K Unit), by End User 2025 & 2033
- Figure 77: Asia Pacific APAC Diabetes Care Devices Industry Revenue Share (%), by End User 2025 & 2033
- Figure 78: Asia Pacific APAC Diabetes Care Devices Industry Volume Share (%), by End User 2025 & 2033
- Figure 79: Asia Pacific APAC Diabetes Care Devices Industry Revenue (Million), by Country 2025 & 2033
- Figure 80: Asia Pacific APAC Diabetes Care Devices Industry Volume (K Unit), by Country 2025 & 2033
- Figure 81: Asia Pacific APAC Diabetes Care Devices Industry Revenue Share (%), by Country 2025 & 2033
- Figure 82: Asia Pacific APAC Diabetes Care Devices Industry Volume Share (%), by Country 2025 & 2033
List of Tables
- Table 1: Global APAC Diabetes Care Devices Industry Revenue Million Forecast, by Management Devices 2020 & 2033
- Table 2: Global APAC Diabetes Care Devices Industry Volume K Unit Forecast, by Management Devices 2020 & 2033
- Table 3: Global APAC Diabetes Care Devices Industry Revenue Million Forecast, by Monitoring Devices 2020 & 2033
- Table 4: Global APAC Diabetes Care Devices Industry Volume K Unit Forecast, by Monitoring Devices 2020 & 2033
- Table 5: Global APAC Diabetes Care Devices Industry Revenue Million Forecast, by End User 2020 & 2033
- Table 6: Global APAC Diabetes Care Devices Industry Volume K Unit Forecast, by End User 2020 & 2033
- Table 7: Global APAC Diabetes Care Devices Industry Revenue Million Forecast, by Region 2020 & 2033
- Table 8: Global APAC Diabetes Care Devices Industry Volume K Unit Forecast, by Region 2020 & 2033
- Table 9: Global APAC Diabetes Care Devices Industry Revenue Million Forecast, by Management Devices 2020 & 2033
- Table 10: Global APAC Diabetes Care Devices Industry Volume K Unit Forecast, by Management Devices 2020 & 2033
- Table 11: Global APAC Diabetes Care Devices Industry Revenue Million Forecast, by Monitoring Devices 2020 & 2033
- Table 12: Global APAC Diabetes Care Devices Industry Volume K Unit Forecast, by Monitoring Devices 2020 & 2033
- Table 13: Global APAC Diabetes Care Devices Industry Revenue Million Forecast, by End User 2020 & 2033
- Table 14: Global APAC Diabetes Care Devices Industry Volume K Unit Forecast, by End User 2020 & 2033
- Table 15: Global APAC Diabetes Care Devices Industry Revenue Million Forecast, by Country 2020 & 2033
- Table 16: Global APAC Diabetes Care Devices Industry Volume K Unit Forecast, by Country 2020 & 2033
- Table 17: United States APAC Diabetes Care Devices Industry Revenue (Million) Forecast, by Application 2020 & 2033
- Table 18: United States APAC Diabetes Care Devices Industry Volume (K Unit) Forecast, by Application 2020 & 2033
- Table 19: Canada APAC Diabetes Care Devices Industry Revenue (Million) Forecast, by Application 2020 & 2033
- Table 20: Canada APAC Diabetes Care Devices Industry Volume (K Unit) Forecast, by Application 2020 & 2033
- Table 21: Mexico APAC Diabetes Care Devices Industry Revenue (Million) Forecast, by Application 2020 & 2033
- Table 22: Mexico APAC Diabetes Care Devices Industry Volume (K Unit) Forecast, by Application 2020 & 2033
- Table 23: Global APAC Diabetes Care Devices Industry Revenue Million Forecast, by Management Devices 2020 & 2033
- Table 24: Global APAC Diabetes Care Devices Industry Volume K Unit Forecast, by Management Devices 2020 & 2033
- Table 25: Global APAC Diabetes Care Devices Industry Revenue Million Forecast, by Monitoring Devices 2020 & 2033
- Table 26: Global APAC Diabetes Care Devices Industry Volume K Unit Forecast, by Monitoring Devices 2020 & 2033
- Table 27: Global APAC Diabetes Care Devices Industry Revenue Million Forecast, by End User 2020 & 2033
- Table 28: Global APAC Diabetes Care Devices Industry Volume K Unit Forecast, by End User 2020 & 2033
- Table 29: Global APAC Diabetes Care Devices Industry Revenue Million Forecast, by Country 2020 & 2033
- Table 30: Global APAC Diabetes Care Devices Industry Volume K Unit Forecast, by Country 2020 & 2033
- Table 31: Brazil APAC Diabetes Care Devices Industry Revenue (Million) Forecast, by Application 2020 & 2033
- Table 32: Brazil APAC Diabetes Care Devices Industry Volume (K Unit) Forecast, by Application 2020 & 2033
- Table 33: Argentina APAC Diabetes Care Devices Industry Revenue (Million) Forecast, by Application 2020 & 2033
- Table 34: Argentina APAC Diabetes Care Devices Industry Volume (K Unit) Forecast, by Application 2020 & 2033
- Table 35: Rest of South America APAC Diabetes Care Devices Industry Revenue (Million) Forecast, by Application 2020 & 2033
- Table 36: Rest of South America APAC Diabetes Care Devices Industry Volume (K Unit) Forecast, by Application 2020 & 2033
- Table 37: Global APAC Diabetes Care Devices Industry Revenue Million Forecast, by Management Devices 2020 & 2033
- Table 38: Global APAC Diabetes Care Devices Industry Volume K Unit Forecast, by Management Devices 2020 & 2033
- Table 39: Global APAC Diabetes Care Devices Industry Revenue Million Forecast, by Monitoring Devices 2020 & 2033
- Table 40: Global APAC Diabetes Care Devices Industry Volume K Unit Forecast, by Monitoring Devices 2020 & 2033
- Table 41: Global APAC Diabetes Care Devices Industry Revenue Million Forecast, by End User 2020 & 2033
- Table 42: Global APAC Diabetes Care Devices Industry Volume K Unit Forecast, by End User 2020 & 2033
- Table 43: Global APAC Diabetes Care Devices Industry Revenue Million Forecast, by Country 2020 & 2033
- Table 44: Global APAC Diabetes Care Devices Industry Volume K Unit Forecast, by Country 2020 & 2033
- Table 45: United Kingdom APAC Diabetes Care Devices Industry Revenue (Million) Forecast, by Application 2020 & 2033
- Table 46: United Kingdom APAC Diabetes Care Devices Industry Volume (K Unit) Forecast, by Application 2020 & 2033
- Table 47: Germany APAC Diabetes Care Devices Industry Revenue (Million) Forecast, by Application 2020 & 2033
- Table 48: Germany APAC Diabetes Care Devices Industry Volume (K Unit) Forecast, by Application 2020 & 2033
- Table 49: France APAC Diabetes Care Devices Industry Revenue (Million) Forecast, by Application 2020 & 2033
- Table 50: France APAC Diabetes Care Devices Industry Volume (K Unit) Forecast, by Application 2020 & 2033
- Table 51: Italy APAC Diabetes Care Devices Industry Revenue (Million) Forecast, by Application 2020 & 2033
- Table 52: Italy APAC Diabetes Care Devices Industry Volume (K Unit) Forecast, by Application 2020 & 2033
- Table 53: Spain APAC Diabetes Care Devices Industry Revenue (Million) Forecast, by Application 2020 & 2033
- Table 54: Spain APAC Diabetes Care Devices Industry Volume (K Unit) Forecast, by Application 2020 & 2033
- Table 55: Russia APAC Diabetes Care Devices Industry Revenue (Million) Forecast, by Application 2020 & 2033
- Table 56: Russia APAC Diabetes Care Devices Industry Volume (K Unit) Forecast, by Application 2020 & 2033
- Table 57: Benelux APAC Diabetes Care Devices Industry Revenue (Million) Forecast, by Application 2020 & 2033
- Table 58: Benelux APAC Diabetes Care Devices Industry Volume (K Unit) Forecast, by Application 2020 & 2033
- Table 59: Nordics APAC Diabetes Care Devices Industry Revenue (Million) Forecast, by Application 2020 & 2033
- Table 60: Nordics APAC Diabetes Care Devices Industry Volume (K Unit) Forecast, by Application 2020 & 2033
- Table 61: Rest of Europe APAC Diabetes Care Devices Industry Revenue (Million) Forecast, by Application 2020 & 2033
- Table 62: Rest of Europe APAC Diabetes Care Devices Industry Volume (K Unit) Forecast, by Application 2020 & 2033
- Table 63: Global APAC Diabetes Care Devices Industry Revenue Million Forecast, by Management Devices 2020 & 2033
- Table 64: Global APAC Diabetes Care Devices Industry Volume K Unit Forecast, by Management Devices 2020 & 2033
- Table 65: Global APAC Diabetes Care Devices Industry Revenue Million Forecast, by Monitoring Devices 2020 & 2033
- Table 66: Global APAC Diabetes Care Devices Industry Volume K Unit Forecast, by Monitoring Devices 2020 & 2033
- Table 67: Global APAC Diabetes Care Devices Industry Revenue Million Forecast, by End User 2020 & 2033
- Table 68: Global APAC Diabetes Care Devices Industry Volume K Unit Forecast, by End User 2020 & 2033
- Table 69: Global APAC Diabetes Care Devices Industry Revenue Million Forecast, by Country 2020 & 2033
- Table 70: Global APAC Diabetes Care Devices Industry Volume K Unit Forecast, by Country 2020 & 2033
- Table 71: Turkey APAC Diabetes Care Devices Industry Revenue (Million) Forecast, by Application 2020 & 2033
- Table 72: Turkey APAC Diabetes Care Devices Industry Volume (K Unit) Forecast, by Application 2020 & 2033
- Table 73: Israel APAC Diabetes Care Devices Industry Revenue (Million) Forecast, by Application 2020 & 2033
- Table 74: Israel APAC Diabetes Care Devices Industry Volume (K Unit) Forecast, by Application 2020 & 2033
- Table 75: GCC APAC Diabetes Care Devices Industry Revenue (Million) Forecast, by Application 2020 & 2033
- Table 76: GCC APAC Diabetes Care Devices Industry Volume (K Unit) Forecast, by Application 2020 & 2033
- Table 77: North Africa APAC Diabetes Care Devices Industry Revenue (Million) Forecast, by Application 2020 & 2033
- Table 78: North Africa APAC Diabetes Care Devices Industry Volume (K Unit) Forecast, by Application 2020 & 2033
- Table 79: South Africa APAC Diabetes Care Devices Industry Revenue (Million) Forecast, by Application 2020 & 2033
- Table 80: South Africa APAC Diabetes Care Devices Industry Volume (K Unit) Forecast, by Application 2020 & 2033
- Table 81: Rest of Middle East & Africa APAC Diabetes Care Devices Industry Revenue (Million) Forecast, by Application 2020 & 2033
- Table 82: Rest of Middle East & Africa APAC Diabetes Care Devices Industry Volume (K Unit) Forecast, by Application 2020 & 2033
- Table 83: Global APAC Diabetes Care Devices Industry Revenue Million Forecast, by Management Devices 2020 & 2033
- Table 84: Global APAC Diabetes Care Devices Industry Volume K Unit Forecast, by Management Devices 2020 & 2033
- Table 85: Global APAC Diabetes Care Devices Industry Revenue Million Forecast, by Monitoring Devices 2020 & 2033
- Table 86: Global APAC Diabetes Care Devices Industry Volume K Unit Forecast, by Monitoring Devices 2020 & 2033
- Table 87: Global APAC Diabetes Care Devices Industry Revenue Million Forecast, by End User 2020 & 2033
- Table 88: Global APAC Diabetes Care Devices Industry Volume K Unit Forecast, by End User 2020 & 2033
- Table 89: Global APAC Diabetes Care Devices Industry Revenue Million Forecast, by Country 2020 & 2033
- Table 90: Global APAC Diabetes Care Devices Industry Volume K Unit Forecast, by Country 2020 & 2033
- Table 91: China APAC Diabetes Care Devices Industry Revenue (Million) Forecast, by Application 2020 & 2033
- Table 92: China APAC Diabetes Care Devices Industry Volume (K Unit) Forecast, by Application 2020 & 2033
- Table 93: India APAC Diabetes Care Devices Industry Revenue (Million) Forecast, by Application 2020 & 2033
- Table 94: India APAC Diabetes Care Devices Industry Volume (K Unit) Forecast, by Application 2020 & 2033
- Table 95: Japan APAC Diabetes Care Devices Industry Revenue (Million) Forecast, by Application 2020 & 2033
- Table 96: Japan APAC Diabetes Care Devices Industry Volume (K Unit) Forecast, by Application 2020 & 2033
- Table 97: South Korea APAC Diabetes Care Devices Industry Revenue (Million) Forecast, by Application 2020 & 2033
- Table 98: South Korea APAC Diabetes Care Devices Industry Volume (K Unit) Forecast, by Application 2020 & 2033
- Table 99: ASEAN APAC Diabetes Care Devices Industry Revenue (Million) Forecast, by Application 2020 & 2033
- Table 100: ASEAN APAC Diabetes Care Devices Industry Volume (K Unit) Forecast, by Application 2020 & 2033
- Table 101: Oceania APAC Diabetes Care Devices Industry Revenue (Million) Forecast, by Application 2020 & 2033
- Table 102: Oceania APAC Diabetes Care Devices Industry Volume (K Unit) Forecast, by Application 2020 & 2033
- Table 103: Rest of Asia Pacific APAC Diabetes Care Devices Industry Revenue (Million) Forecast, by Application 2020 & 2033
- Table 104: Rest of Asia Pacific APAC Diabetes Care Devices Industry Volume (K Unit) Forecast, by Application 2020 & 2033
Frequently Asked Questions
1. What is the projected Compound Annual Growth Rate (CAGR) of the APAC Diabetes Care Devices Industry?
The projected CAGR is approximately 3.50%.
2. Which companies are prominent players in the APAC Diabetes Care Devices Industry?
Key companies in the market include Terumo, Dexcom, Insulin Devices, Roche Diabetes Care, Eli Lilly, Sanofi, Abbott Diabetes Care, Medtronic, LifeScan (Johnson & Johnson), Becton Dickinson, Novo Nordisk A/S, Arkray.
3. What are the main segments of the APAC Diabetes Care Devices Industry?
The market segments include Management Devices, Monitoring Devices, End User.
4. Can you provide details about the market size?
The market size is estimated to be USD 22.77 Million as of 2022.
5. What are some drivers contributing to market growth?
Rising Prevalence of Cancer Worldwide; Technological Advancements in Diagnostic Testing; Increasing Demand for Point-of-care Treatment.
6. What are the notable trends driving market growth?
The continuous glucose monitoring segment is expected to witness a healthy growth rate over the forecast period.
7. Are there any restraints impacting market growth?
High Cost of Molecular Diagnostic Tests; Lack of Skilled Workforce and Stringent Regulatory Framework.
8. Can you provide examples of recent developments in the market?
November 2023: Sibionics, a Chinese company, has recently received a CE Mark for its GS1 continuous glucose monitoring system (CGM). This innovative wearable device utilizes an under-the-skin sensor to accurately measure glucose levels in real-time. The collected data is then seamlessly transmitted to a connected handset or mobile phone. The GS1 CGM provides users with a remarkable 14-day continuous glucose monitoring experience, eliminating the need for frequent calibration. Additionally, it empowers users to effortlessly transmit their glucose data to monitoring devices or mobile apps, enabling them to generate comprehensive and insightful professional reports.
9. What pricing options are available for accessing the report?
Pricing options include single-user, multi-user, and enterprise licenses priced at USD 4750, USD 5250, and USD 8750 respectively.
10. Is the market size provided in terms of value or volume?
The market size is provided in terms of value, measured in Million and volume, measured in K Unit.
11. Are there any specific market keywords associated with the report?
Yes, the market keyword associated with the report is "APAC Diabetes Care Devices Industry," which aids in identifying and referencing the specific market segment covered.
12. How do I determine which pricing option suits my needs best?
The pricing options vary based on user requirements and access needs. Individual users may opt for single-user licenses, while businesses requiring broader access may choose multi-user or enterprise licenses for cost-effective access to the report.
13. Are there any additional resources or data provided in the APAC Diabetes Care Devices Industry report?
While the report offers comprehensive insights, it's advisable to review the specific contents or supplementary materials provided to ascertain if additional resources or data are available.
14. How can I stay updated on further developments or reports in the APAC Diabetes Care Devices Industry?
To stay informed about further developments, trends, and reports in the APAC Diabetes Care Devices Industry, consider subscribing to industry newsletters, following relevant companies and organizations, or regularly checking reputable industry news sources and publications.
Methodology
Step 1 - Identification of Relevant Samples Size from Population Database
Step 2 - Approaches for Defining Global Market Size (Value, Volume* & Price*)
Note*: In applicable scenarios
Step 3 - Data Sources
Primary Research
- Web Analytics
- Survey Reports
- Research Institute
- Latest Research Reports
- Opinion Leaders
Secondary Research
- Annual Reports
- White Paper
- Latest Press Release
- Industry Association
- Paid Database
- Investor Presentations
Step 4 - Data Triangulation
Involves using different sources of information in order to increase the validity of a study
These sources are likely to be stakeholders in a program - participants, other researchers, program staff, other community members, and so on.
Then we put all data in single framework & apply various statistical tools to find out the dynamic on the market.
During the analysis stage, feedback from the stakeholder groups would be compared to determine areas of agreement as well as areas of divergence